Robb Knie - Net Worth and Insider Trading
Robb Knie Net Worth
The estimated net worth of Robb Knie is at least $48,249 dollars as of 2024-11-29. Robb Knie is the CEO and President of Hoth Therapeutics Inc and owns about 58,131 shares of Hoth Therapeutics Inc (HOTH) stock worth over $48,249. Details can be seen in Robb Knie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robb Knie has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robb Knie
Robb Knie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robb Knie owns 4 companies in total, including Hoth Therapeutics Inc (HOTH) , Inventergy Global Inc (INVT) , and FoxWayne Enterprises Acquisition Corp (FOXW) among others .
Click here to see the complete history of Robb Knie’s form 4 insider trades.
Insider Ownership Summary of Robb Knie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HOTH | Hoth Therapeutics Inc | 2024-08-16 | director & CEO and President |
| INVT | Inventergy Global Inc | 2014-06-06 | director |
| FOXW | FoxWayne Enterprises Acquisition Corp | 2021-01-19 | director & Chairman and CEO |
 | | 2021-01-19 | director & Chairman and CEO |
Robb Knie Latest Holdings Summary
Robb Knie currently owns a total of 1 stock. Robb Knie owns 58,131 shares of Hoth Therapeutics Inc (HOTH) as of August 16, 2024, with a value of $48,249.
Latest Holdings of Robb Knie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HOTH | Hoth Therapeutics Inc | 2024-08-16 | 58,131 | 0.83 | 48,249 |
Holding Weightings of Robb Knie
Robb Knie Form 4 Trading Tracker
According to the SEC Form 4 filings, Robb Knie has made a total of 3 transactions in Hoth Therapeutics Inc (HOTH) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Hoth Therapeutics Inc is the acquisition of 25,000 shares on August 16, 2024, which cost Robb Knie around $16,750.
Insider Trading History of Robb Knie
- 1
Robb Knie Trading Performance
GuruFocus tracks the stock performance after each of Robb Knie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robb Knie is -39.11%. GuruFocus also compares Robb Knie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robb Knie within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robb Knie's insider trading performs compared to the benchmark.
Performance of Robb Knie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.99 | | | | | |
| Relative Return to S&P 500(%) | 8.77 | | | | | |
Robb Knie Ownership Network
Robb Knie Owned Company Details
What does Hoth Therapeutics Inc do?
Who are the key executives at Hoth Therapeutics Inc?
Robb Knie is the director & CEO and President of Hoth Therapeutics Inc. Other key executives at Hoth Therapeutics Inc include Chief Scientific Officer Stefanie Johns , 10 percent owner Spherix Inc , and Chief Financial Officer David S. Briones .
Hoth Therapeutics Inc (HOTH) Insider Trades Summary
Over the past 18 months, Robb Knie made 1 insider transaction in Hoth Therapeutics Inc (HOTH) with a net purchase of 25,000.
In summary, during the past 3 months, insiders sold 0 shares of Hoth Therapeutics Inc (HOTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hoth Therapeutics Inc (HOTH) were sold and 25,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Hoth Therapeutics Inc (HOTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hoth Therapeutics Inc Insider Transactions
Robb Knie Mailing Address
Above is the net worth, insider trading, and ownership report for Robb Knie. You might contact Robb Knie via mailing address: C/o Inventergy Global, Inc., 900 East Hamilton Avenue Suite 180, Campbell Ca 95008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
